YOLFTbeta
30

Beijing Leadman Biochemistry Co Ltd

300289 · SHE · Healthcare / Medical Devices

6.00CNY-0.15 (-2.44%)

Price History

Full chart

Market Stats

Previous Close6.15
Open6.19
Day Range5.95 – 6.19
52-Week Range5.19 – 10.41
Volume8.43M
Market Cap3.30B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.05
Dividend Yield0.00%
Beta0.21
50-Day Avg5.83
200-Day Avg6.41

About

Beijing Leadman Biochemistry Co.,Ltd. researches and develops, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People's Republic of China. The company offers biochemical raw materials, including enzymes, antigens, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain agents, amino acids, and other products for biotechnology, clinical diagnosis, drug development, chemical production, and other related applications. It also provides biochemical reagents for liver function, lipid profile, diabetes reagents, pancreas function, tumor detection, protein and others, multi calibrators and multi co, semi-quantitative assays, coagulation reagents, cardiac marker, cardiac reagents, electrolytes, and renal function; companion reagents regents for tumor, thyroid hormone, sex hormone, infectious disease, and others; and IDS-compatible luminescent reagents. In addition, it offers testing instruments. Beijing Leadman Biochemistry Co.,Ltd. was founded in 1997 and is based in Beijing, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Ouyang Xu
  • Employees405
  • HeadquartersNo.5 Xinghai Road, Beijing, China, 100176, China
  • Websitehttps://www.leadmanbio.com

Leadership

  • Mr. Ouyang XuHead of Finance & Accounting Supoervisor · b. 1984
  • Mr. Yaoliang DingVice President · b. 1975
  • Ms. Li Hua ZhangVP & Secretary · b. 1979
  • Lan Zhen WangTechnical Director
  • Mr. Kun ZhangDirector of Human Resources & Administrative Center · b. 1971

Financials

Income Statement

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue103.81M143.27M185.62M252.08M317.27M343.63M536.97M681.68M533.39M575.98M654.80M515.14M471.51M564.06M705.98M461.55M370.23M326.31M
Growth (%)-+38.01%+29.57%+35.80%+25.86%+8.31%+56.26%+26.95%-21.75%+7.98%+13.69%-21.33%-8.47%+19.63%+25.16%-34.62%-19.79%-11.86%
Cost of Revenue41.94M57.19M65.40M96.70M119.62M126.61M205.48M287.88M239.09M258.68M332.04M239.83M215.87M269.78M407.77M198.01M186.35M162.83M
Gross Profit61.87M86.08M120.22M155.39M197.66M217.02M331.50M393.79M294.30M317.30M322.76M275.31M255.64M294.28M298.20M263.55M183.88M163.48M
Gross Margin59.60%60.08%64.77%61.64%62.30%63.16%61.73%57.77%55.18%55.09%49.29%53.44%54.22%52.17%42.24%57.10%49.67%50.10%
Operating Expense27.32M38.28M58.33M72.23M86.61M91.76M169.75M195.29M198.67M200.15M249.97M243.91M263.43M234.09M290.64M239.64M257.60M187.00M
Operating Income34.56M47.80M61.90M83.15M111.05M125.27M161.74M198.51M95.63M117.15M72.79M31.40M-7.79M60.19M7.56M23.91M-73.72M-23.52M
Operating Margin33.29%33.36%33.35%32.99%35.00%36.45%30.12%29.12%17.93%20.34%11.12%6.10%-1.65%10.67%1.07%5.18%-19.91%-7.21%
EBITDA38.51M53.39M69.09M93.97M126.06M147.72M232.25M276.07M159.29M169.19M121.02M79.75M40.18M116.64M35.06M84.30M-18.31M31.39M
EBITDA Margin37.10%37.27%37.22%37.28%39.73%42.99%43.25%40.50%29.86%29.37%18.48%15.48%8.52%20.68%4.97%18.26%-4.94%9.62%
Net Income26.16M41.41M54.40M71.85M98.29M110.07M128.28M157.22M69.65M73.07M40.47M6.31M-50.98M22.42M-56.27M15.34M-75.10M-22.98M
Net Income Margin25.20%28.91%29.31%28.50%30.98%32.03%23.89%23.06%13.06%12.69%6.18%1.22%-10.81%3.97%-7.97%3.32%-20.29%-7.04%
R&D5.09M6.22M11.73M16.22M23.09M24.38M28.00M29.43M31.45M36.58M39.97M48.31M38.47M32.75M34.96M36.87M32.95M24.12M
R&D as % of Total Revenue4.91%4.34%6.32%6.43%7.28%7.09%5.21%4.32%5.90%6.35%6.10%9.38%8.16%5.81%4.95%7.99%8.90%7.39%
Interest Expense495.63K506.67K1.45M3.28M2.36M2.61M19.23M15.36M8.26M9.67M7.84M4.14M2.80M2.30M1.39M737.02K371.73K192.91K
Interest Expense % of Total Revenue0.48%0.35%0.78%1.30%0.75%0.76%3.58%2.25%1.55%1.68%1.20%0.80%0.59%0.41%0.20%0.16%0.10%0.06%

Balance Sheet

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets113.91M153.00M258.71M365.66M1.13B1.24B1.62B1.66B1.66B1.75B1.73B1.71B1.63B2.35B2.00B1.94B1.82B1.78B
Total Liabilities30.01M47.68M98.99M144.89M369.17M392.86M523.48M398.76M326.13M328.73M291.80M264.18M249.92M370.30M216.67M133.77M103.84M105.46M
Total Equity83.90M105.32M159.72M220.77M761.02M851.12M964.51M1.19B1.24B1.31B1.31B1.32B1.26B1.84B1.73B1.74B1.66B1.64B
Cash28.20M42.80M100.76M49.56M432.20M327.77M105.09M177.77M199.70M305.37M269.72M295.68M352.53M928.60M798.81M565.02M574.27M566.02M
Total Debt5.00M25.00M70.80M121.00M246.45M236.45M166.68M136.60M149.77M166.01M116.86M56.50M63.97M79.29M59.13M4.65M721.13K-
Net Debt-23.20M-17.80M-29.96M71.44M-185.75M-91.32M61.59M-41.16M-49.94M-139.36M-152.86M-239.18M-288.57M-849.31M-739.68M-560.37M-573.55M-

Cash Flow

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow21.98M31.26M53.46M29.34M57.86M90.45M-13.21M177.82M81.78M120.97M81.02M124.65M135.56M119.06M108.93M134.42M62.41M29.16M
Investing Cash Flow-5.89M-14.64M-38.32M-113.07M-232.50M-145.31M-138.02M-24.72M-23.31M-10.81M-16.13M-25.88M-23.70M-42.33M-213.11M-355.46M-39.11M-
Financing Cash Flow-5.50M-4.57M22.98M47.12M563.40M-48.51M-71.26M-80.30M-37.99M-4.29M-99.99M-82.60M-45.74M499.15M-24.76M-12.26M-16.47M-
Capital Expenditure6.04M15.06M38.63M113.50M242.17M153.34M19.16M24.72M23.31M10.90M12.24M26.28M28.39M44.50M39.12M18.69M29.23M17.59M
Free Cash Flow15.94M16.20M14.84M-84.15M-184.31M-62.90M-32.37M153.09M58.47M110.06M68.78M98.37M107.17M74.56M69.81M112.11M33.18M11.57M
Dividends Paid495.63K20.51M1.45M15.23M31.31M39.57M45.18M54.79M49.79M24.03M18.96M5.78M4.18M403.12K10.88M201.33K5.44M-
FCF to OCF72.51%51.81%27.75%-286.76%-318.57%-69.54%245.09%86.10%71.50%90.99%84.89%78.92%79.06%62.62%64.09%83.40%53.17%39.69%
Dividend Paid to FCF3.11%126.60%9.75%-18.10%-16.99%-62.90%-139.57%35.79%85.16%21.83%27.57%5.88%3.90%0.54%15.58%0.18%16.40%-

Earnings

Report DateMar 31, 2012Jun 30, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 21, 2014Oct 26, 2014Feb 16, 2015Apr 22, 2015Aug 28, 2015Oct 22, 2015Feb 24, 2016Apr 27, 2016Aug 18, 2016Oct 28, 2016Feb 28, 2017Apr 25, 2017Aug 25, 2017Oct 27, 2017Feb 27, 2018Apr 27, 2018Aug 27, 2018Oct 29, 2018Dec 31, 2018Apr 22, 2019Aug 20, 2019Oct 26, 2019Apr 28, 2020Aug 15, 2020Oct 29, 2020Apr 28, 2021Aug 13, 2021Oct 25, 2021Mar 19, 2022Apr 23, 2022Aug 19, 2022Oct 22, 2022Mar 25, 2023Apr 21, 2023Aug 12, 2023Oct 24, 2023Mar 28, 2024Apr 29, 2024Aug 17, 2024Oct 26, 2024Apr 29, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------0.040.08----0.100.07-------------------------------
EPS Actual0.060.090.070.060.060.100.080.040.030.080.060.160.040.090.070.180.040.040.030.050.040.060.040.030.040.050.05-0.050.010.010.01-0.010.020.030.010.020.03-0.010.020.020.02-0.170.020.020.01-0.02-0.010.010.00-0.00-0.01-0.01-0.03-0.01-0.01
Surprise----------------0.00%-50.00%-----60.00%-57.14%-------------------------------
Timing---------Pre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-market-Pre-market-----------------After-hours--After-hours-----

Key Statistics & Ratios

Market Cap3.30B
Enterprise Value2.33B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales10.37
Price / Book1.99
EPS-0.05
Book Value3.00
Revenue (TTM)317.79M
Gross Profit (TTM)135.93M
EBITDA7.68M
Profit Margin-8.14%
Operating Margin-10.44%
Return on Equity-1.63%
Return on Assets-1.28%
Shares Outstanding544.01M
Shares Float290.74M
Beta0.21
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
0.01May 17, 2024
20221×
0.02May 19, 2022
20201×
0.01Jun 8, 2020
20181×
0.03Jul 6, 2018
20171×
0.01Jun 15, 2017
20161×
0.06Jun 16, 2016
20151×
0.06May 27, 2015
20141×
0.06Jun 6, 2014
20131×
0.05Jun 13, 2013
20121×
0.04May 22, 2012

Stock Splits

  • Oct 27, 201525:10